Common Contracts
2 similar Underwriting Agreement contracts by Eton Pharmaceuticals, Inc., TFF Pharmaceuticals, Inc.
TFF PHARMACEUTICALS, inc. 19,896,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • August 15th, 2023 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
TFF Pharmaceuticals, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to The Benchmark Company, LLC (the “Underwriter”), an aggregate of 19,896,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriter, up to 2,984,400 additional shares (the “Additional Shares”), in each case of common stock, par value $0.001 per share (the “Common Stock”) of the Company, in an offering under its registration statement on Form S-3 (File No. 333-249870) (the Firm Shares and the Additional Shares being collectively called the “Shares”).
ETON PHARMACEUTICALS, INC. 2,800,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • October 14th, 2020 • Eton Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Eton Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to National Securities Corporation (the “Underwriter”), an aggregate of 2,800,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriter, up to 420,000 additional shares (the “Additional Shares”), in each case of common stock, par value $0.001 per share (the “Common Stock”) of the Company, in an offering under its registration statement on Form S-3 (File No. 333-235329) (the Firm Shares and the Additional Shares being collectively called the “Shares”).
